Science to Business: The Evolution of Organizational Leadership in Pharma

Science to Business Network Presents...

Pharma Insights with Paul Petrelli: The Evolution of Organizational Leadership in the Pharmaceutical Industry

Session Objectives

• Review emerging trends in the healthcare sector that are driving the need to adapt
• Highlight leadership skills for future growth and adaptability in a dynamic industry
• Outline the opportunities to navigate and drive effective change in the healthcare and pharmaceutical industry of tomorrow

Host: Brian Knight, Ph.D, MBA
With Guest Speaker: Paul Petrelli (General Manager, Jazz Pharmaceuticals; Chairman, Executive Committee, BIOTECanada)

Wednesday, December 5, 2018

Brazen Head

165 East Liberty St, Toronto

6:00 pm Event Registration + Networking (cash/credit bar)
6:30 pm Presentation + Q&A

7:30 pm Networking Reception (light snacks provided - cash/credit bar)

Early Bird Online Tickets (Eventbrite):

Member - $5

Non-member (student) - $15

Non-member (industry professional) - $20

At the Door Ticket Prices:

Member - $10

Non-member - $30

Note: online processing fees not included.

**Memberships - NEW for 2018/2019**

2018 - 2019 Membership Fee (student) - Only $40

2018 - 2019 Membership Fee (industry professional) - Only $75

As an S2BN Member, you will join a community of like-minded academics and professionals who strive to improve health and life sciences innovation in Canada. Working together, we will play an essential role in building bridges between academia, government and industry, and fostering the development of future leaders in Canada's life and health sciences sector.

Your membership will help support S2BN's mission of delivering quality events and novel programs to the S2BN community.

Members will receive:

• Discounted entry to any S2BN event across Canada
• Priority registration
• Access to an S2BN members-only networking event

Please note: Memberships are non-transferable and valid from Sept. 2018 - Aug. 2019.

Speaker Biograpy:

Paul Petrelli

A business leader in the Biotechnology/Pharmaceutical Industry, Paul has a proven track record of performance and experience leading people and businesses in biotechnology and rare disease, both in Canada and the United States. His experience includes building and growing businesses with companies such as GlaxoSmithKline, AstraZeneca, Biogen and currently, Jazz Pharmaceuticals. His 20 years of proven success is built on extensive launch experience, lifecycle management and breadth of understanding in sales, marketing, market access, medical, government relations and regulatory affairs. Paul’s experience transcends the financials, he also lead organizations in creating a winning culture, being recognized as a Great Place to Work in Canada for multiple years.

Paul’s commitment to business and people leadership goes beyond his current role; he is an active board member with The Lymphoma and Leukemia Society of Canada, The Biomedical Discovery and Commercialization Program at McMaster University, Department of Biochemistry and Biomedical Sciences, and serves as chair of Biotech Canada. Paul also contributes as Director–in–Residence with the Rotman School of Management, Director of Education Program, as a member of the Capital Access Advisor Program, Ontario Bioscience Innovation Organization. Additionally, he serves as faculty on the Marketing Pharmaceuticals in Canada Program, the National Pharmaceutical Congress and is a Member of the Life Sciences Advisory Consortium, City of Mississauga.

Paul has a Bachelors degree in Biology, Genetics, from the University of Toronto and is a graduate of the Institute of Corporate Directors program at the Rotman School of Management, University of Toronto.

Host Biography:

Brian Knight, PhD, MBA

Brian Knight earned a B.Sc (honours physiology & psychology) from Western University (London, Canada) and Ph.D. (physiological genomics) from University of Toronto (Toronto). He later completed his MBA at the Rotman School of Management (Toronto). Dr Knight then worked as a management consultant for RWS and Optimus SBR, advising healthcare organizations. He later joined Roche to lead innovation. Brian then co-founded the Exponential Exchange, a digital advertising agency. Brian is currently the president of Knight Labs Inc, a creative agency that he founded that offers an innovative approach to building audience engagement for its clients. Brian also guest lectures at the University of Toronto and serves on the board of directors for the Science to Business Network (S2BN).